Prestige Consumer Healthcare (PBH) Other Non Operating Income (2010 - 2025)
Prestige Consumer Healthcare (PBH) posted quarterly Other Non Operating Income of -$10.0 million for Q4 2025, up 15.27% year-over-year from -$8.7 million in Q4 2024, and down 1897.01% quarter-over-quarter from -$501000.0 in Q3 2025.
Prestige Consumer Healthcare (PBH) Other Non Operating Income (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Other Non Operating Income history runs 16 years deep, the most recent figure standing at -$10.0 million for Q4 2025.
- In Q4 2025, Other Non Operating Income rose 15.27% year-over-year to -$10.0 million; the TTM figure through Dec 2025 stood at -$14.0 million (down 154.35% YoY), while the FY2025 annual figure was -$5.0 million, down 55144.44% from the prior year.
- Other Non Operating Income for Q4 2025 stood at -$10.0 million, down from -$501000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $51.6 million in Q1 2024, with the low at -$91.0 million in Q1 2021.
- The 5-year median for Other Non Operating Income is -$2.4 million (2022), against an average of -$10.7 million.
- The sharpest annual moves came in 2021 and 2024: Other Non Operating Income tumbled 149620.0% in 2021, then soared 11337.25% in 2024.
- Prestige Consumer Healthcare's Other Non Operating Income stood at -$17.1 million in 2021, then surged by 93.28% to -$1.2 million in 2022, then soared by 40.7% to -$682000.0 in 2023, then plunged by 1631.38% to -$11.8 million in 2024, then advanced by 15.27% to -$10.0 million in 2025.
- Business Quant data shows PBH's Other Non Operating Income at -$10.0 million in Q4 2025, -$501000.0 in Q3 2025, and $224000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Prestige Consumer Healthcare | 2.42 Bn | 2.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10.01 Mn |
| Sep 30, 2025 | -501,000.00 |
| Jun 30, 2025 | 224,000.00 |
| Mar 31, 2025 | -3.71 Mn |
| Dec 31, 2024 | -11.81 Mn |
| Sep 30, 2024 | -395,000.00 |
| Jun 30, 2024 | -13.63 Mn |
| Mar 31, 2024 | 51.58 Mn |
| Dec 31, 2023 | -682,000.00 |
| Sep 30, 2023 | -17.84 Mn |
| Jun 30, 2023 | 1.24 Mn |
| Mar 31, 2023 | 451,000.00 |
| Dec 31, 2022 | -1.15 Mn |
| Sep 30, 2022 | -812,000.00 |
| Jun 30, 2022 | 790,000.00 |
| Mar 31, 2022 | -65.34 Mn |
| Dec 31, 2021 | -17.10 Mn |
| Sep 30, 2021 | -18.93 Mn |
| Jun 30, 2021 | -14.97 Mn |
| Mar 31, 2021 | -90.96 Mn |